Natco Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524816	NSE Symbol:	NATCOPHARM	P/E :	11.28
ISIN Demat:	INE987B01026	Div & Yield %:	0.63	EPS :	83.75
Book Value:	461.80	Market Cap (Rs. Cr.):	16,916.03	Face Value :	2

Date	Headline
14-Feb-26	Natco Pharma receives CDSCO approval for launch of Semaglutide in India
13-Feb-26	Natco Pharma receives USFDA EIR report for API unit in Chennai
12-Feb-26	Board of Natco Pharma recommends interim dividend
03-Feb-26	NATCO Pharma receives USFDA tentative approval for Erdafitinib tablets
30-Jan-26	NATCO Pharma Asia acquires 49% stake in PT NATCO Lotus Farma
28-Jan-26	Natco Pharma to hold board meeting
02-Dec-25	Natco Pharma announces change in senior management
29-Nov-25	Natco Pharma receives affirmation in credit ratings from ICRA
21-Nov-25	Natco Pharma concludes USFDA inspection of its API unit in Chennai
14-Nov-25	Board of Natco Pharma recommends interim dividend

Company Snapshot